Aclaris therapeutics to participate in the h.c. wainwright bioconnect virtual conference

Wayne, pa., dec. 27, 2021 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that dr. neal walker, president and ceo of aclaris, will participate in a fireside chat at the h.c. wainwright bioconnect virtual conference, which will be available beginning on monday, january 10, 2022 at 7:00 a.m. et.
ACRS Ratings Summary
ACRS Quant Ranking